Drugs

NuPathe Appoints Bart J. Dunn as Vice President, Corporate Development & Licensing

CONSHOHOCKEN, PA: CONSHOHOCKEN, PA -- (Marketwire) -- 11/02/11 -- NuPathe Inc. (NASDAQ: PATH), an emerging biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseas ...

Theravance to Present at Investor Conferences in November 2011

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 11/01/11 -- Theravance, Inc. (NASDAQ: THRX) announced today that Rick E Winningham, Chief Executive Officer, is scheduled to present at the following invest ...

Cytokinetics Announces Initiation of Second Cohort of Ongoing Phase II Clinical Trial Evaluating CK-2017357 in Patients With ALS

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 11/01/11 -- Cytokinetics, Incorporated (NASDAQ: CYTK) announced today the initiation of a second cohort, or Part B, of an ongoing Phase II clinical trial o ...

IBC Life Sciences Kicks Off the Annual BioProcess International(TM) Conference & Exhibition in Long Beach, California

WESTBOROUGH, MA: WESTBOROUGH, MA -- (Marketwire) -- 10/31/11 -- Today IBC kicks off its annual BioProcess International Conference & Exhibition in Long Beach, California. Every year this event brings together bi ...

Flamel Technologies Announces Projected Release Date of Third Quarter Results; Conference Call

LYON, FRANCE: LYON, FRANCE -- (Marketwire) -- 10/27/11 -- Flamel Technologies (NASDAQ: FLML) expects to release its financial results for the third quarter of 2011 on Wednesday, November 2nd, after the market clo ...

Taconic and Oncodesign(R) Announce Agreement to Co-Promote and Co-Develop Solutions to Advance Oncology Research

HUDSON, NY and DIJON, FRANCE: HUDSON, NY and DIJON, FRANCE -- (Marketwire) -- 10/27/11 -- Taconic, a leading provider of life sciences solutions, and Oncodesign®, an innovative leader in the discovery of novel anti-cancer thera ...

International Journal of Radiation Oncology, Biology and Physics Publishes Cleveland BioLabs Study of CBLB502 Protection From Radiation Dermatitis and Oral Mucositis in Head and Neck Cancer Model

BUFFALO, NY: BUFFALO, NY -- (Marketwire) -- 10/24/11 -- Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced pre-publication of a study demonstrating CBLB502's ability to both protect from local radiation ...

Critical Outcome Technologies Inc. Announces Warrant Term Amendments

LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwire) -- 10/21/11 -- Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT) announced today that it has received acceptance from the TSX Venture Exchange (TSXV) to am ...

Late Stage Drugs From BioSante and AEterna Zentaris Could Reawaken Interest in Biotech Sector

NEW YORK, NY: The Paragon Report Provides Equity Research on BioSante Pharmaceuticals & AEterna Zentaris ...

PharmStar Outstanding Common Stock Reduced by 50%

WILSON, NC: WILSON, NC -- (Marketwire) -- 10/17/11 -- PharmStar Pharmaceuticals, Inc., (PINKSHEETS: PHAR) (the "Company") today announced that its management and Board of Directors have directed a &qu ...